Average Target Price - R$ 4.62
| Consensus |
2024E |
2025E |
| Net sales (R$ million) |
R$ 27,197 |
R$ 28,838 |
| Gross margin (%) |
30.9% |
31.1% |
| Adjusted EBITDA (R$ million) |
R$ 1,813 |
R$ 2,313 |
| Financial result (R$ million) |
-R$ 1,350 |
-R$ 1,299 |
| Net income (R$ million) |
-R$ 869 |
-R$ 965 |
TARGET PRICE (Sell) - R$ 3.80
| Banco do Brasil projections |
2024E |
2025E |
| Net sales (R$ million) |
R$ 27,235 |
R$ 28,617 |
| Gross margin (%) |
30.7% |
29.3% |
| Adjusted EBITDA (R$ million) |
R$ 1,947 |
R$ 2,075 |
| Financial result (R$ million) |
R$ (1,639) |
R$ (2,540) |
</tr
| Net income (R$ million) |
R$ (604) |
R$ (1,095) |
TARGET PRICE (Sell) - R$ 3.25
| BofA Merrill Lynch projections |
2024E |
2025E |
| Net sales(R$ million) |
R$ 26,714 |
R$ 28,133 |
| Gross margin (%) |
– |
– |
| Adjusted EBITDA (R$ million) |
– |
– |
| Financial result (R$ million) |
– |
– |
| Net income (R$ million) |
-R$ 936 |
-R$ 1,266 |
TARGET PRICE (Neutral) - R$ 9.00
| Bradesco projections |
2024E |
2025E |
| Net sales (R$ million) |
R$ 28,697 |
R$ 30,512 |
| Gross margin (%) |
– |
– |
| Adjusted EBITDA (R$ million) |
R$ 2,058 |
R$ 3,008 |
| Financial result (R$ million) |
– |
– |
| Net income (R$ million) |
-R$ 1.086 |
R$ 0 |
TARGET PRICE (Neutral) - R$ 3.00
| BTG Pactual projections |
2024E |
2025E |
| Net sales(R$ million) |
R$ 27,031 |
R$ 28,637 |
| Gross margin (%) |
30.8% |
31.6% |
| Adjusted EBITDA (R$ million) |
R$ 1,939 |
R$ 2,561 |
| Financial result (R$ million) |
– |
– |
| Net income (R$ million) |
R$ (689) |
R$ (754) |
TARGET PRICE (Sell) - R$ 4.00
| Genial projections |
2024E |
2025E |
| Net sales(R$ million) |
R$ 28,156 |
R$ 29,715 |
| Gross margin (%) |
30.40% |
31.10% |
| Adjusted EBITDA (R$ million) |
R$ 2,114 |
R$ 2,692 |
| Financial result (R$ million) |
-R$ 2,510 |
-R$ 2,326 |
| Net income (R$ million) |
-R$ 1,274 |
-R$ 602 |
TARGET PRICE (Sell) - R$ 2.90
| Goldman Sachs projections |
2024E |
2025E |
| Net sales (R$ million) |
R$ 26,827 |
R$ 28,285 |
| Gross margin (%) |
– |
– |
| Adjusted EBITDA (R$ million) |
R$ 1,722 |
R$ 2,318 |
| Financial result (R$ million) |
– |
– |
| Net income (R$ million) |
-R$ 847 |
-R$ 1,393 |
TARGET PRICE (Sell) - -
| Morgan Stanley projections |
2024E |
2025E |
| Net sales(R$ million) |
R$ 26.822 |
R$ 28.788 |
| Gross margin (%) |
30.9% |
31.4% |
| Adjusted EBITDA (R$ million) |
R$ 1,919 |
R$ 2,418 |
| Financial result (R$ million) |
R$ (1,945) |
R$ (2,928) |
| Net income (R$ million) |
R$ (857) |
R$ (1.164) |
TARGET PRICE (Sell) - R$ 3.20
| Safra projections |
2024E |
2025E |
| Net sales (R$ million) |
R$ 26,935 |
R$ 28,886 |
| Gross margin (%) |
31.4% |
31.5% |
| Adjusted EBITDA (R$ million) |
R$ 2,385 |
R$ 2,970 |
| Financial result (R$ million) |
– |
– |
| Net income (R$ million) |
-R$ 861 |
-R$ 905 |
TARGET PRICE (Neutral) - R$ 3.90
| Santander projections |
2024E |
2025E |
| Net sales(R$ million) |
R$ 27,072 |
R$ 28,674 |
| Gross margin (%) |
30.9% |
31.5% |
| Adjusted EBITDA (R$ million) |
R$ 1,928 |
R$ 2,552 |
| Financial result (R$ million) |
-R$ 2,004< |
-R$ 0 |
| Net income (R$ million) |
-R$ 813 |
-R$ 1,020 |
TARGET PRICE (Neutral) - R$ 8.00
| XP projections |
2024E |
2025E |
| Net sales(R$ million) |
R$ 31.377 |
– |
| Gross margin (%) |
29.70% |
– |
| Adjusted EBITDA (R$ million) |
R$ 2.066 |
– |
| Financial result (R$ million) |
– |
– |
| Net income (R$ million) |
-R$ 1.051 |
-/td>
|
Contraste
Acessibility 
